Organogenesis Ownership | Who Owns Organogenesis?


OverviewForecastRevenueFinancialsChartTranscripts

Organogenesis Ownership Summary


Organogenesis is owned by 11.73% institutional investors, 47.46% insiders, and 40.81% retail investors. Morgan stanley is the largest institutional shareholder, holding 9.17% of ORGO shares. Xtrackers S&P 500 Swap ETF 1C is the top mutual fund, with 2.54% of its assets in Organogenesis shares.

ORGO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockOrganogenesis11.73%47.46%40.81%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustrySpecialty & Generic Drug Manufacturers Stocks20.67%13.90%65.43%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Morgan stanley11.62M9.17%$27.53M
Soleus capital management10.09M7.96%$23.90M
Vanguard group4.96M3.91%$25.69M
Blackrock funding, inc. /de4.90M3.87%$11.61M
Blackrock5.09M3.86%$14.24M
First light asset management3.50M2.76%$8.29M
Dimensional fund advisors lp2.89M2.28%$6.85M
D. e. shaw2.30M1.81%$5.45M
Assenagon asset management1.97M1.55%$4.66M
Geode capital management1.78M1.41%$4.23M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Pharvision advisers16.30K11.86%$38.64K
Soleus capital management10.09M0.97%$23.90M
First light asset management3.50M0.74%$8.29M
Highmark wealth management303.03K0.29%$718.18K
Sphera funds management550.00K0.21%$1.30M
Kent lake capital151.91K0.19%$425.33K
Wealth dimensions group407.96K0.19%$966.88K
Intrepid family office73.58K0.14%$174.38K
Ajovista15.51K0.13%$43.44K
Oxford asset management llp37.84K0.04%$89.69K

Top Buyers

HolderShares% AssetsChange
Norges bank1.10M0.00%1.10M
Sphera funds management550.00K0.21%550.00K
Vanguard fiduciary trust498.45K0.00%498.45K
Los angeles capital management491.84K0.00%363.96K
D. e. shaw2.30M0.00%309.50K

Top Sellers

HolderShares% AssetsChange
Assenagon asset management1.97M0.01%-3.57M
Driehaus capital management---1.80M
Deutsche bank ag\1.71M0.00%-1.59M
Jane street group129.33K--752.35K
Healthcare of ontario pension plan trust fund---649.90K

New Positions

HolderShares% AssetsChangeValue
Norges bank1.10M0.00%1.10M$5.69M
Sphera funds management550.00K0.21%550.00K$1.30M
Vanguard fiduciary trust498.45K0.00%498.45K$1.18M
Exoduspoint capital management, lp276.91K0.01%276.91K$656.29K
Kent lake capital151.91K0.19%151.91K$425.33K

Sold Out

HolderChange
Ifp advisors-1.00
Aster capital management (difc)-1.00
Assetmark-4.00
Pnc financial services group-5.00
Northwestern mutual wealth management-10.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202648-67.35%14,864,263-78.61%110.39%17-77.33%16-66.67%
Dec 31, 2025107-11.57%57,735,956-15.59%451.56%48-9.43%38-17.39%
Sep 30, 2025114-68,359,384-1.48%531.80%48-5.88%44-6.38%
Jun 30, 2025113-17.52%69,296,6277.39%542.09%50-32.43%472.17%
Mar 31, 202513613.33%64,503,6783.15%512.30%7417.46%4631.43%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Xtrackers S&P 500 Swap ETF 1C3.22M2.54%-23.78K
Xtrackers S&P 500 2xLev Dly Swap ETF 1C2.41M1.82%-
Xtrackers S&P Global Infra Swap ETF 1C2.08M1.64%-
Vanguard Total Stock Mkt Idx Inv1.99M1.55%-
iShares Russell 2000 ETF1.63M1.27%13.77K
Vanguard US Total Market Shares ETF1.59M1.25%-
Invesco Consumer Discr S&P US SelSec ETF1.54M1.21%1.54M
Vanguard Institutional Extnd Mkt Idx Tr845.17K0.66%-
Heptagon Driehaus US Micro Cap Eq C$ Acc703.51K0.55%-9.64K
Fidelity Small Cap Index666.79K0.52%4.54K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 09, 2026Leibowitz Arthur S-Buy$13.40K
Mar 09, 2026Driscoll Michael Joseph-Buy$26.69K
Dec 16, 2025NUSSDORF GLENN H-Sell$1.03M
Nov 25, 2025NUSSDORF GLENN H Sell$63.83K
Nov 24, 2025NUSSDORF GLENN H Sell$534.00K

Insider Transactions Trends


DateBuySell
2026 Q11-
2025 Q4-4
2025 Q3--
2025 Q23-
2025 Q1-1

ORGO Ownership FAQ


Who Owns Organogenesis?

Organogenesis shareholders are primarily institutional investors at 11.73%, followed by 47.46% insiders and 40.81% retail investors. The average institutional ownership in Organogenesis's industry, Specialty & Generic Drug Manufacturers Stocks, is 20.67%, which Organogenesis falls below.

Who owns the most shares of Organogenesis?

Organogenesis’s largest shareholders are Morgan stanley (11.62M shares, 9.17%), Soleus capital management (10.09M shares, 7.96%), and Vanguard group (4.96M shares, 3.91%). Together, they hold 21.03% of Organogenesis’s total shares outstanding.

Does Blackrock own Organogenesis?

Yes, BlackRock owns 3.86% of Organogenesis, totaling 5.09M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 14.24M$. In the last quarter, BlackRock increased its holdings by 112.84K shares, a 2.27% change.

Who is Organogenesis’s biggest shareholder by percentage of total assets invested?

Pharvision advisers is Organogenesis’s biggest shareholder by percentage of total assets invested, with 11.86% of its assets in 16.3K Organogenesis shares, valued at 38.64K$.

Who is the top mutual fund holder of Organogenesis shares?

Xtrackers S&P 500 Swap ETF 1C is the top mutual fund holder of Organogenesis shares, with 2.54% of its total shares outstanding invested in 3.22M Organogenesis shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools